Abstract
There have been tremendous advances in the ability to screen for the "odds" of having a genetic disorder (both mendelian and chromosomal). With microarray analyses on fetal tissue now showing a minimum risk for any pregnancy being at least 1 in 150 and ultimately greater than 1%, it is thought that all patients, regardless of age, should be offered chorionic villus sampling/amniocentesis and microarray analysis. As sequencing techniques replace other laboratory methods, the only question will be whether these tests are performed on villi, amniotic fluid cells, or maternal blood.
Original language | English |
---|---|
Pages (from-to) | 193-208 |
Number of pages | 16 |
Journal | Obstetrics and Gynecology Clinics of North America |
Volume | 42 |
Issue number | 2 |
DOIs | |
State | Published - 1 Jun 2015 |
Keywords
- Amniocentesis
- Chorionic villus sampling
- Chromosomal
- Fetal reduction
- Genetic disorder
- Mendelian
- Multiple pregnancies
- Pre-implantation diagnosis